VEGF and CXCL1 are potent proangiogenic factors, and their co-enrichment with TGF-β reinforces the notion that these vesicles could enhance vascular remodeling in the tumor stroma or at distant metastatic sites [20,41]. The gene discussed is TGFB1; the disease is neoplasm.